Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Mease

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
Seminars in Arthritis and Rheumatism|February 18, 2021
Measurement properties of radiographic outcome measures in Psoriatic Arthritis: A systematic review from the GRAPPA-OMERACT initiativeAnna Antony, Richard Holland, Maria-Antonietta D'Agostino, et al.
Arthritis Care & Research|November 8, 2021
Biopsychosocial Rehabilitation for Inflammatory Arthritis and Osteoarthritis Patients: A Systematic Review and Meta-Analysis of Randomized TrialsMorten B Pedersen, Peter Thinggaard, Rinie Geenen, et al.
The Journal of Rheumatology|June 7, 2007
Fibromyalgia syndromePhilip Mease, Lesley M Arnold, Robert Bennett, et al.
Clinical Immunology (Orlando, Fla.)|August 17, 2017
The unmet need in rheumatology: Reports from the targeted therapies meeting 2017Kevin L Winthrop, Vibeke Strand, Désirée van der Heijde, et al.
Lancet (London, England)|October 27, 2018
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trialPhilip Mease, Laura C Coates, Philip S Helliwell, et al.
The Journal of Rheumatology|February 16, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) MeetingCarmel Stober, Deepak R Jadon, April W Armstrong, et al.
Annals of the Rheumatic Diseases|August 8, 2020
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world dataPhilip Mease, Christina Charles-Schoeman, Stanley Cohen, et al.
Nature Reviews. Rheumatology|November 27, 2025
Consensus definitions of complex-to-manage and treatment-refractory psoriatic arthritis: a GRAPPA initiativeFabian Proft, Andre L Ribeiro, Shikha Singla, et al.
The Journal of Investigative Dermatology|May 18, 2026
AI versus Experts: Navigating Challenging Cases in Psoriatic DiseaseLourdes M Pérez-Chada, Victoria Garfinkel, Beth A Childs, et al.
Seminars in Arthritis and Rheumatism|October 18, 2017
A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiativePil Højgaard, Louise Klokker, Ana-Maria Orbai, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Seminars in Arthritis and Rheumatism|February 18, 2021
Measurement properties of radiographic outcome measures in Psoriatic Arthritis: A systematic review from the GRAPPA-OMERACT initiativeAnna Antony, Richard Holland, Maria-Antonietta D'Agostino, et al.
Arthritis Care & Research|November 8, 2021
Biopsychosocial Rehabilitation for Inflammatory Arthritis and Osteoarthritis Patients: A Systematic Review and Meta-Analysis of Randomized TrialsMorten B Pedersen, Peter Thinggaard, Rinie Geenen, et al.
The Journal of Rheumatology|June 7, 2007
Fibromyalgia syndromePhilip Mease, Lesley M Arnold, Robert Bennett, et al.
Clinical Immunology (Orlando, Fla.)|August 17, 2017
The unmet need in rheumatology: Reports from the targeted therapies meeting 2017Kevin L Winthrop, Vibeke Strand, Désirée van der Heijde, et al.
Lancet (London, England)|October 27, 2018
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trialPhilip Mease, Laura C Coates, Philip S Helliwell, et al.
The Journal of Rheumatology|February 16, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) MeetingCarmel Stober, Deepak R Jadon, April W Armstrong, et al.
Annals of the Rheumatic Diseases|August 8, 2020
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world dataPhilip Mease, Christina Charles-Schoeman, Stanley Cohen, et al.
Nature Reviews. Rheumatology|November 27, 2025
Consensus definitions of complex-to-manage and treatment-refractory psoriatic arthritis: a GRAPPA initiativeFabian Proft, Andre L Ribeiro, Shikha Singla, et al.
The Journal of Investigative Dermatology|May 18, 2026
AI versus Experts: Navigating Challenging Cases in Psoriatic DiseaseLourdes M Pérez-Chada, Victoria Garfinkel, Beth A Childs, et al.
Seminars in Arthritis and Rheumatism|October 18, 2017
A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiativePil Højgaard, Louise Klokker, Ana-Maria Orbai, et al.
Pageof 18